Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
ACTO Field Excellence Platform
product2 mentionslast seen Oct 5, 2026
AI-powered platform for field excellence in Life Sciences.
Relationships 4
- ACTO Field Excellence Platformconforms toFDA 21 CFR Part 1199% confidence2 sources
- ACTOdevelopsACTO Field Excellence Platform99% confidence2 sources
- ACTO Field Excellence Platformapplies toLife Sciences commercial operations90% confidence1 source
- ACTO Field Excellence Platformdepends onagentic AI85% confidence1 source
Relationship
ACTO Field Excellence Platformconforms toFDA 21 CFR Part 11
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireOct 5, 2026ACTO Named a Luminary in Everest Group's "Innovation Watch: Agentic AI in Life Sciences Commercial 2026"
ACTO is FDA 21 CFR Part 11 validated
- newsPR NewswireOct 5, 2026ACTO Named a Luminary in Everest Group's "Innovation Watch: Agentic AI in Life Sciences Commercial 2026"
ACTO is FDA 21 CFR Part 11 validated